The company has an R&D facility for Formulations Development. As the global economy is on a recovery path, our thrust continues to be a research-driven company. Low product costs and intellectual property will be the most definitive drivers in domestic and international generics market for Hetero Healthcare Ltd. We have proven excellence in this regard.
The aim here is to devise formulations and dosage forms for new drugs to be introduced and make variants of particular dosage forms. Another objective is to introduce drug combinations by understanding the interaction mechanism and the combined effects in increasing intensity of response, decreasing untoward actions, and altering absorption.
The therapeutic range covers Antibiotics, Analgesics, Antihistamines, Antihypertensive, Antidiabetics, Vitamins, Antioxidants, NSAIDs, Psychotropic, Nutritional products, Antiemetic, Anti-allergic, Cardio Vascular, Hormones, Anti-infective, Oncology, Steroids Genitourinary System, Ophthalmic, Dermatology, SC/IV/IM & Sterile Products, Biologicals, Proteins, Peptides and Drug-Device Combination Products.
With access to state-of-the-art facilities and the knowledge to handle complex requirements, our customer base includes the top global pharmaceutical companies. Our goals aligned with our philosophy – to understand our customers' needs and deliver solutions that contribute to their success. We provide our clients with an efficient, inexpensive and timely experience that includes smooth transfer management. Offering the latest equipment and international expertise allows companies to take advantage of our quick response times and reliable delivery. Our dedication to our clients and their business ensures a strong product capable of competing in domestic and international markets.
The pursuit of scientific excellence guides everything we do. To achieve scientific leadership, we are changing the way we work, making the most of our capabilities and building those we need.
Copyright ©2024 All Rights Reserved by Hetero Healthcare Limited.